کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2529999 | 1120424 | 2011 | 7 صفحه PDF | دانلود رایگان |

Few common neurological illnesses trace back to single molecular disturbances. Many disparate putative causes may co-associate with a single disease state. However, uncovering functional, hierarchical networks of underlying mechanisms can provide a framework in which many primary pathologies converge on more complex, single higher level correlates of disease. This article focuses on cognitive deficits associated with schizophrenia to illustrate: a) How non-invasive EEG biomarkers of cognitive function constitute such a ‘higher level correlate’ of underlying pathologies. b) How derangement of multiple, cell-specific, molecular processes can converge on such EEG-visible, correlates of disrupted cognitive function. This approach suggests that evidence-based design of multi-target therapies may take advantage of hierarchical patterns of convergence to improve both efficacy and selectivity of disease-intervention.
► In this article we consider the mechanisms underlying cognitive deficit in schizophrenia.
► We show that a hierarchy of dynamic processes contributes to the deficit.
► We illustrate the prospect of selective intervention at the level of brain dynamics: ‘rhythm repair’.
► Evidence reveals that many multireceptor actions of antipsychotics converge on interneuron function underlying gamma rhythms.
► We suggest that evidence-based polypharmacy may allow tailoring of therapy to individual patient needs.
Journal: Current Opinion in Pharmacology - Volume 11, Issue 5, October 2011, Pages 508–514